LOBEF (LOBEF) Stock Price & Analysis
LOBEF (LOBEF) fell 18.67% to USD 0.07 as of June 10, 2026 at 05:13 UTC, according to Nexqual real-time market data.
LOBEF last closed at USD 0.09; the session ranged USD 0.07–0.07 on volume of 5,800 shares. Market capitalization is $20.54M, with a 52-week range of USD 0–0.07 (OQB). Source: Nexqual, June 10, 2026 at 05:13 UTC.
Key Statistics (as of June 10, 2026 at 05:13 UTC)
| Price | USD 0.07 |
|---|---|
| Change | ▼ 18.67% (down) |
| Previous Close | USD 0.09 |
| Open | USD 0.07 |
| Day Range | USD 0.07 – 0.07 |
| 52-Week Range | USD 0 – 0.07 |
| Volume | 5,800 shares |
| Market Cap | $20.54M |
| Exchange | OQB |
Technical Analysis (LOBEF)
Nexqual's technical model rates LOBEF "SELL" based on 2 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 05:13 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.67 (neutral) |
| vs SMA50 | Above (USD 0.01) |
| MACD | -0 (negative) |
Analyst Ratings (LOBEF)
Wall Street analysts rate LOBEF "None", per Nexqual as of June 10, 2026 at 05:13 UTC.
| Consensus Rating | None |
|---|
Earnings (LOBEF)
Source: Nexqual, June 10, 2026 at 05:13 UTC.
Financials & Fundamentals (LOBEF)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Debt / Equity | 17.16 |
| Current Ratio | 1.75 |
| Total Cash | $4.96M |
| Total Debt | $316,486 |
| Free Cash Flow | $-2.34M |
Source: Nexqual, June 10, 2026 at 05:13 UTC.
Financial Health Score (LOBEF)
Nexqual rates LOBEF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 05:13 UTC.
| Growth | Critical — Revenue -63% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — $5M cash, no debt |
| Cash Flow | Weak — FCF negative: -$2M, burning cash |
| Efficiency | Mixed — No data |
Ownership (LOBEF)
| Insider Ownership | +44.97% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 284.10M |
| Float | 172.17M |
Source: Nexqual, June 10, 2026 at 05:13 UTC.
Leadership (LOBEF)
LOBEF is led by Frederick Dominick Sancilio M.S. (age 75), Chairman & CEO, per Nexqual as of June 10, 2026 at 05:13 UTC.
| Chairman & CEO | Frederick Dominick Sancilio M.S. (age 75) |
|---|---|
| President | Charles F. Goulburn (age 63) |
| Chief Financial Officer | Mirza Rahimani (age 45) |
| Senior Vice President of Quality and Operations | Robert Miller |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GMVDF | G Medical Innovations Holdings | USD 0 | ▲ 0% |
| AOXG | Aoxing Pharmaceutical Company, | USD 0 | ▼ 19.23% |
| BBUZ | Bebuzee Inc. | USD 0.02 | ▲ 10.56% |
| KCRD | Kindcard Inc. | USD 0.03 | ▲ 0% |
| BIOAF | BIOASIS TECHNOLOGIES INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:13 UTC. This page is informational and not investment advice.